Mario Maggi
Papers
1
Total Citations
5
H-Index
1
About
Mario Maggi is a leading urological surgeon and researcher whose work centers on erectile dysfunction following prostate cancer surgery, particularly robotic-assisted prostatectomy. His major contributions focus on optimizing post-surgical sexual function through comparative studies of phosphodiesterase type 5 inhibitors. In his most cited work, a prospective multicentre study, Maggi directly compared the efficacy and safety of avanafil 200 mg versus sildenafil 100 mg after robot-assisted unilateral nerve-sparing prostatectomy. This research was groundbreaking because it was the first to evaluate avanafil—a second-generation PDE5 inhibitor with high selectivity—in this specific post-operative context, providing critical evidence for tailored pharmacological rehabilitation. With over 5 citations on this key paper alone, Maggi’s work has shaped clinical guidelines for erectile dysfunction management in prostate cancer survivors. His research is notable for its rigorous comparative design and focus on improving quality of life after nerve-sparing surgery, making him a respected authority in the field of sexual medicine and urological oncology.
Research Focus
Key Achievements
Top Papers
- 1